Evidence map›Paper›PMID 25804397›Full record

SynthesisEuropean journal of human genetics : EJHG2015

Deciphering associations for lung cancer risk through imputation and analysis of 12,316 cases and 16,831 controls.

Yufei Wang, Yongyue Wei, Valerie Gaborieau, Jianxin Shi, Younghun Han, Maria N Timofeeva, Li Su, Yafang Li, Timothy Eisen, Christopher I Amos and 4 more

Abstract readMeta-Analysis
In one paragraph

Synthesis in European journal of human genetics : EJHG, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 6 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 6 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Article
  8. Article
  9. Article
  10. Article
  11. Causal Estimation of Long-term Intervention Cost-effectiveness Using Genetic Instrumental Variables: An Application to Cancer.Medical decision making : an international journal of the Society for Medical Decision Making · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. A Decade of GWAS Results in Lung Cancer.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Yufei WangDivision of Genetics and Epidemiology, The Institute of Cancer Research, Surrey, Sutton, UK.
Yongyue WeiDepartment of Environmental Health, Harvard School of Public Health, Boston, MA, USA.ORCID http://orcid.org/0000-0002-1132-1796
Valerie GaborieauInternational Agency for Research on Cancer (IARC, World Health Organization (WHO)), Lyon, France.
Jianxin ShiDivision of Cancer Epidemiology and Genetics, National Cancer institute, NIH, DHHS, Bethesda, MD, USA.
Younghun HanDepartment of Community and Family Medicine, Geisel School of Medicine, Center for Genomic Medicine, Lebanon, NH, USA.
Maria N TimofeevaInternational Agency for Research on Cancer (IARC, World Health Organization (WHO)), Lyon, France.
Li SuDepartment of Environmental Health, Harvard School of Public Health, Boston, MA, USA.
Yafang LiDepartment of Community and Family Medicine, Geisel School of Medicine, Center for Genomic Medicine, Lebanon, NH, USA.
Timothy EisenAddenbrooke's Hospital, Cambridge Biomedical Campus, Cambridge, UK.
Christopher I AmosDepartment of Community and Family Medicine, Geisel School of Medicine, Center for Genomic Medicine, Lebanon, NH, USA.
Maria Teresa LandiDepartment of Health and Human Services, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health (NIH), Bethesda, MD, USA.
David C ChristianiDepartment of Environmental Health, Harvard School of Public Health, Boston, MA, USA.
James D McKayInternational Agency for Research on Cancer (IARC, World Health Organization (WHO)), Lyon, France.
Richard S HoulstonDivision of Genetics and Epidemiology, The Institute of Cancer Research, Surrey, Sutton, UK.

Funding

Translational Engineering in Cancer (TEC)P30CA023108 · NCI · DARTMOUTH COLLEGE · PI Fred W Kolling IV · 1985 to 2026
$91.3M
THE CAROTENE AND RETINOL EFFICACY TRIAL (CARET)U01CA063673 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI GOODMAN, GARY E · 1994 to 2006
$13.0M
Translational studies of Hsp90 inhibitors in NSCLCP50CA090578 · NCI · DANA-FARBER CANCER INST · PI YEAP, BEOW Y · 2008 to 2012
$11.4M
Statistical Methods for Analysis of Massive Genetic and Genomic Data in Cancer ResearchR35CA197449 · NCI · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · PI XIHONG LIN · 2015 to 2026
$10.9M
Transdisciplinary Research in Cancer of the Lung (TRICL)U19CA148127 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI AMOS, CHRISTOPHER I., LE MARCHAND, LOIC · 2010 to 2014
$10.9M
Molecular and Genetic Analysis of Lung Cancer SurvivalR01CA092824 · NCI · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI CHRISTIANI, DAVID C · 2002 to 2013
$5.9M
ECOGENETIC STUDY OF LUNG CANCER IN MINORITIESR01CA055769 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI SPITZ, MARGARET R · 1991 to 2008
$5.3M
SPORE in Lung CancerP20CA090578 · NCI · DANA-FARBER CANCER INSTITUTE · PI JOHNSON, BRUCE E. · 2003 to 2007
$5.1M
GENETIC SUSCEPTIBILITY TO LUNG CANCERR01CA074386 · NCI · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI CHRISTIANI, DAVID C · 1997 to 2008
$4.8M
GENETICS OF TOBACCO AND ALCOHOL RELATED CANCERSR01CA092039 · NCI · INTERNATIONAL AGENCY FOR RES ON CANCER · PI BRENNAN, PAUL JOSEPH · 2003 to 2010
$3.6M
Inflammation Genes and Lung Cancer RiskR01CA127219 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI SPITZ, MARGARET R · 2008 to 2013
$3.1M
High Density Association Analysis of Lung CancerR01CA121197 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI AMOS, CHRISTOPHER I. · 2007 to 2010
$3.0M
Cancer Research UK C1298/A8362Cancer Research UK C1298/A8780NCI NIH HHS 5R01CA055769NCI NIH HHS 5R01CA121197NCI NIH HHS 5R01CA127219NCI NIH HHS 5R01CA133996NCI NIH HHS CA074386NCI NIH HHS CA090578NCI NIH HHS CA092824NCI NIH HHS P20 CA090578NCI NIH HHS P30 CA023108NCI NIH HHS P50 CA090578NCI NIH HHS R01 CA055769NCI NIH HHS R01 CA074386NCI NIH HHS R01 CA092039NCI NIH HHS R01 CA092824NCI NIH HHS R01 CA111703NCI NIH HHS R01 CA121197NCI NIH HHS R01 CA127219NCI NIH HHS R01 CA133996NCI NIH HHS R35 CA197449NCI NIH HHS U01 CA063673NCI NIH HHS U19 CA148127NCI NIH HHS U19CA148127NCI NIH HHS UO1 CA63673World Health Organization 001
6 · The paper itself

Abstract

Recent genome-wide association studies have identified common variants at multiple loci influencing lung cancer risk. To decipher the genetic basis of the association signals at 3q28, 5p15.33, 6p21.33, 9p21 and 12p13.33, we performed a meta-analysis of data from five genome-wide association studies in populations of European ancestry totalling 12 316 lung cancer cases and 16 831 controls using imputation to recover untyped genotypes. For four of the regions, it was possible to refine the association signal identifying a smaller region of interest likely to harbour the functional variant. Our analysis did not provide evidence that any of the associations at the loci being a consequence of synthetic associations rather than linkage disequilibrium with a common risk variant at these risk loci.

Indexed as

Genetic LociAdultAgedCase-Control StudiesFemaleGenome-Wide Association StudyHumansLung NeoplasmsMaleMiddle Aged

Identifiers

PMID25804397
PMCPMC4795209

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.